Feedback Here

fbook  tweeter  linkin  google
Global contents also translated in Chinese

Kraig Labs’ provisional patent applications to reduce future R&D costs

The five new provisional patent applications by Kraig Biocraft Laboratories, Inc can reduce future R&D costs and break open new markets for recombinant protein products, reaching far beyond silks and apparel. These applications cover a broad range of technologies in the creation, screening, and production of new recombinant proteins. They expand beyond the company’s publicly disclosed silkworm and silk technologies, to include advanced construction systems, methods, and non-native proteins.

In November, of 2018, the company retained Workman Nydegger as its Intellectual Property counsel and expects to utilise their expertise in prosecuting these, and all future, patent applications. Kraig Biocraft Laboratories is a fully reporting biotechnology company focused on the commercialisation of new textiles and high performance fibers including spider silks. As the leading developer of genetically engineered spider silk based fiber technologies, Kraig Biocraft has been able to achieve a series of scientific breakthroughs in the area of spider silk technology.